دورية أكاديمية

Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study

التفاصيل البيبلوغرافية
العنوان: Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study
المؤلفون: Wray, Sibyl, Then Bergh, Florian, Wundes, Annette, Arnold, Douglas L., Drulovic, Jelena, Jasinska, Elzbieta, Bowen, James D., Negroski, Donald, Naismith, Robert T., Hunter, Samuel F., Gudesblatt, Mark, Chen, Hailu, Lyons, Jennifer, Shankar, Sai L., Kapadia, Shivani, Mendoza, Jason P., Singer, Barry A.
المصدر: Advances in Therapy ; volume 39, issue 4, page 1810-1831 ; ISSN 0741-238X 1865-8652
بيانات النشر: Springer Science and Business Media LLC
سنة النشر: 2022
مصطلحات موضوعية: Pharmacology (medical), General Medicine
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1007/s12325-022-02068-7
DOI: 10.1007/s12325-022-02068-7.pdf
DOI: 10.1007/s12325-022-02068-7/fulltext.html
الإتاحة: https://doi.org/10.1007/s12325-022-02068-7Test
حقوق: https://creativecommons.org/licenses/by-nc/4.0Test ; https://creativecommons.org/licenses/by-nc/4.0Test
رقم الانضمام: edsbas.5935D3A8
قاعدة البيانات: BASE